AzTrials
AzTrials

DementiaPhase 1NCT07239869

A Robot-assisted Tailored Activity Programme for People With Dementia and Their Caregivers

A Phase 1 study testing Intervention in people with Dementia and Caregiver, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

To assess the feasibility and preliminary efficacy of the tailored activity programme on improving the physical inactivity of the caregiving dyads. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Dementia, Caregiver, Physical Activity
What is being tested?
Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteHong Kong
Study dates
1 Sep 2025to 31 Aug 2026
Phase
Phase 1
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • mild to moderate stage dementia at a standardized mini-mental state examination score (MMSE) higher than 10;
  • be able to walk independently;
  • being physically inactive (categorized as "low/inactive" by the International Physical Activity Questionnaire);
  • free from other medical/functional conditions that would limit physical activity.
  • primary informal caregivers who reside with the of the person with dementia;
  • have provided care for more than six months;
Show all 9Show fewer
  • have no intention to send the care recipient to nursing homes in the next six months;
  • being physically inactive;
  • use a smartphone.

Who cannot join

  • high risk of falling (Berg Balance Scale <45);
  • not be suitable for doing physical activity as recommended by the primary care physician;
  • currently involved in another interventional study involving physical exercise;
  • had acute hospitalization >3 times in the past year.
  • caregivers with unstable physical or mental conditions;
  • cannot communicate logically;
  • not suitable for doing physical activity as recommended by a primary care physician.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Hong Kong1 site, 1 recruiting
  • The Hong Kong Polytechnic University

    Hong Kong

    Shanshan Wang, +85227664696, shan-shan.wang@polyu.edu.hk

    Recruiting

Other trials in Hong Kong

About this study

Official title: An AI Robot-assisted Tailored Activity Programme for Improving the Physical Inactivity of People With Dementia and Their Informal Caregivers

To assess the feasibility and preliminary efficacy of the tailored activity programme on improving the physical inactivity of the caregiving dyads.

Read the detailed description

This is a two-arm pilot randomized controlled trial evaluating the feasiblity and preliminary efficacy of the robot-assisted tailored activity programme on improving the physical inactivity of people with dementia and their caregivers. Sixty dyads will be rectuited. Participants in the intervention group will receive a 12-week tailored activity programme, while those in the control group will receive usal community care services. Outcomes including feasibility of the tailored acitivity programme, physical activity levels, self-efficacy in physical activity, dyadic quality of life, neuropsychiatric somptoms, and psychological wellbeing will be measured at baseline and immediately post intervention.

Being tested
Intervention, Control
Medical subject headings
Dementia, Motor Activity, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • InterventionOther

    12 weeks of robot assisted tailored activity programme

  • ControlOther

    Usual care provided by community centers

Study groups in NCT07239869
Study groupRoleWhat they receive
InterventionExperimentalTweleve weeks of robot-assisted tailored activity programme
Receives: Other: Intervention
ControlOtherUsual care provided by community centers
Receives: Other: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in physical activity

    Physical activity will be measured with the Chinese version of the International Physical Activity Questionnaire short version (IPAQ-C, short). The IPAQ-C is a 9-item instrument with good reliability and validity. Objective mesures will include number of steps, movement distance, sedentary minutes, inactive minutes collected with an activity tracker.

    Measured: Pre-intervention and immediately post-intervention

Secondary outcomes (4)
  1. Changes in self-efficacy in physical activity

    Self-efficacy in physical activity will be measured with a Likert 6-point scale covering three different types of self-efficacy. This instrument demonstrated satisfactory internal consistency. Higher scores indicate higher self-efficacy in physical activity.

    Measured: Pre-intervention and immediately post-intervention

  2. Changes in quality of life

    Dyadic quality of life will be measured with the 12-item Short Form Survey (SF-12). Higher scores indicate better quality of life

    Measured: Pre-intervention and immediately post-intervention

  3. Changes in neuropsychiatric symptoms of people with dementia

    People with dementia's neuropsychiatric symptoms will be measured with the Neuropsychiatric Inventory (NPI). NPI evaluates 12 common neuropsychiatric disturbances in dementia. The Chinese version was reliable. Higher scores indicate worse symptoms

    Measured: Pre-intervention and immediately post-intervention

  4. Changes in psychological well-being

    Dyads' psychological well-being will be measured with the Depression Anxiety Stress Scale-21 (DASS-21). DASS-21 includes 3 subscales (stress, anxiety, and depression), and has demonstrated good reliability among the Chinese population. Higher scores indicate poorer psychological wellbeing and more psychological distress.

    Measured: Pre-intervention and immediately post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2025
  2. Study start1 Sep 2025
  3. Primary completion31 Aug 2026 (estimated)
  4. Study completion31 Aug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07239869
Sponsor's protocol ID
P0044775
Status last verified
Nov 2025
First submitted
16 Nov 2025
Last updated
18 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Intervention in people with Dementia and Caregiver, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 18 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in physical activity (time frame: Pre-intervention and immediately post-intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Dec 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in